Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1988 1
2000 1
2001 1
2004 1
2005 3
2006 2
2007 2
2008 1
2009 2
2010 7
2011 4
2012 2
2013 1
2014 5
2015 2
2016 1
2017 3
2018 4
2019 2
2020 2
2021 5
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.
Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT. Oviedo-Joekes E, et al. Among authors: brissette s. Drug Alcohol Rev. 2018 Jan;37(1):137-146. doi: 10.1111/dar.12573. Epub 2017 Jun 8. Drug Alcohol Rev. 2018. PMID: 28593748 Clinical Trial.
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study.
Elkrief L, Bastien G, McAnulty C, Bakouni H, Hébert FO, Socias ME, Le Foll B, Lim R, Ledjiar O, Marsan S, Brissette S, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Elkrief L, et al. Among authors: brissette s. J Subst Use Addict Treat. 2023 Jun;149:209031. doi: 10.1016/j.josat.2023.209031. Epub 2023 Mar 30. J Subst Use Addict Treat. 2023. PMID: 37003540 Free article. Clinical Trial.
Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial.
Rizkallah E, Mongeau-Pérusse V, Lamanuzzi L, Castenada-Ouellet S, Stip E, Juteau LC, Brissette S, Bruneau J, Dubreucq S, Jutras-Aswad D. Rizkallah E, et al. Among authors: brissette s. Pharmacol Biochem Behav. 2022 May;216:173376. doi: 10.1016/j.pbb.2022.173376. Epub 2022 Mar 31. Pharmacol Biochem Behav. 2022. PMID: 35367279 Free article. Clinical Trial.
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.
Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Bruneau J, Fischer B, Rehm J, Wild TC, Wood E, Brissette S, Gagnon L, Fikowski J, Ledjiar O, Masse B, Socias ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Jutras-Aswad D, et al. Among authors: brissette s. Am J Psychiatry. 2022 Oct;179(10):726-739. doi: 10.1176/appi.ajp.21090964. Epub 2022 Jun 15. Am J Psychiatry. 2022. PMID: 35702828 Clinical Trial.
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial.
McAnulty C, Bastien G, Eugenia Socias M, Bruneau J, Foll BL, Lim R, Brissette S, Ledjiar O, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. McAnulty C, et al. Among authors: brissette s. Drug Alcohol Depend. 2022 Oct 1;239:109604. doi: 10.1016/j.drugalcdep.2022.109604. Epub 2022 Aug 17. Drug Alcohol Depend. 2022. PMID: 36037586 Free article. Clinical Trial.
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
Bastien G, McAnulty C, Ledjiar O, Socias ME, Le Foll B, Lim R, Hassan AN, Brissette S, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Bastien G, et al. Among authors: brissette s. Can J Psychiatry. 2023 Aug;68(8):572-585. doi: 10.1177/07067437221145013. Epub 2022 Dec 14. Can J Psychiatry. 2023. PMID: 36519188 Free PMC article. Clinical Trial.
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial.
Morissette F, Mongeau-Pérusse V, Rizkallah E, Thébault P, Lepage S, Brissette S, Bruneau J, Dubreucq S, Stip E, Cailhier JF, Jutras-Aswad D. Morissette F, et al. Among authors: brissette s. Neuropsychopharmacology. 2021 Nov;46(12):2101-2111. doi: 10.1038/s41386-021-01098-z. Epub 2021 Jul 30. Neuropsychopharmacology. 2021. PMID: 34331010 Free PMC article. Clinical Trial.
Sexual activity and sleep in humans.
Brissette S, Montplaisir J, Godbout R, Lavoisier P. Brissette S, et al. Biol Psychiatry. 1985 Jul;20(7):758-63. doi: 10.1016/0006-3223(85)90155-6. Biol Psychiatry. 1985. PMID: 4005334
58 results